Chen Chi

Dr. Chen Chi


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
DSDi-Yang Sun
Di-Yang Sun
WWWen-Bin Wu
Wen-Bin Wu
JWJian-Jin Wu
Jian-Jin Wu
YSYu Shi
Yu Shi
JXJia-Jun Xu
Jia-Jun Xu
PWPei Wang
Pei Wang
Senescence of vascular smooth muscle cells (VSMCs) contributes to aging-related cardiovascular diseases by promoting arterial remodelling and stiffness. Ferroptosis is a novel type of regulated cell death associated with lipid oxidation. Here, we show that pro-ferroptosis signaling drives VSMCs senescence to accelerate vascular NAD+ loss, remodelling and aging. Pro-ferroptotic signaling is triggered in senescent VSMCs and arteries of aged mice. Furthermore, the activation of pro-ferroptotic signaling in VSMCs not only induces NAD+ loss and senescence but also promotes the release of a pro-senescent secretome. Pharmacological or genetic inhibition of pro-ferroptosis signaling, ameliorates VSMCs senescence, reduces vascular stiffness and retards the progression of abdominal aortic aneurysm in mice. Mechanistically, we revealed that inhibition of pro-ferroptotic signaling facilitates the nuclear-cytoplasmic shuttling of proliferator-activated receptor-γ and, thereby impeding nuclear receptor coactivator 4-ferrtin complex-centric ferritinophagy. Finally, the activated pro-ferroptotic signaling correlates with arterial stiffness in a human proof-of-concept study. These findings have significant implications for future therapeutic strategies aiming to eliminate vascular ferroptosis in senescence- or aging-associated cardiovascular diseases.

25 August 2018 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
CCChen Chi
Chen Chi
JTJiadela Teliewubai
Jiadela Teliewubai
YLYu-Yan Lu
Yu-Yan Lu
XFXimin Fan
Ximin Fan
SYShikai Yu
Shikai Yu
YXYawei Xu
Yawei Xu
Recommendations of non-HDL amplification varied from different guidelines. We aim to test the relationships between various lipid parameters and target organ damage (TOD) including aortic stiffness, peripheral arterial disease and chronic kidney disease in a community-based elderly cohort. 1599 (aged 71.4 ± 6.1 years) participants were recruited. Eight lipid parameters, including total cholesterol (TC), triglycerides (TG), LDL-C, HDL-C, non-HDL-C, TC/HDL ratio, TG/HDL ratio and LDL/HDL ratio, together with other plasma biomarkers like creatinine were measured. Pulse wave velocity (PWV) was measured by the SphygmoCor device, and ankle-brachial index (ABI) was assessed by Omron VP-1000 device. Four individual lipid parameters (TC, TG, LDL-C and HDL-C) significantly correlated with most, but not all, TOD indices. Meanwhile, 4 combined lipid parameters, namely non-HDL-C, TC/HDL, TG/HDL and LCL/HDL, significantly correlated with all TOD (P ≤ 0.033). In multiple linear regression analyses, 4 combined lipid parameters also significantly associated with TOD (P ≤ 0.027), while none of individual lipid parameters significantly associated with all TOD indices. In multiple logistic regression analyses, only non-HDLC and TC/HDL significantly associated with TOD (P ≤ 0.039), and other lipid parameters did not significantly associate with TOD. In an elderly community sample, non-HDLC and TC/HDLC were better associated with TOD than other lipid parameters. This finding should be considered in future clinical lipid-lowing therapy. This trial was retrospectively registered in ClinicalTrials.gov (No. NCT02368938 , registered on 15 Feb 2015).

1 October 2021 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
SZSong Zhao
Song Zhao
ZRZhongyuan Ren
Zhongyuan Ren
SYShikai Yu
Shikai Yu
CCChen Chi
Chen Chi
JTJiamin Tang
Jiamin Tang
yi zhangyi zhang
yi zhang
Introduction: Lipid accumulation product (LAP), calculated from waist circumference (WC) and triglycerides (TG), is a novel index that correlates cardiovascular disease. We aimed to investigate the relationship between LAP and target organ damage (TOD) in elderly Chinese community-dwelling individuals. Materials and Methods: We enrolled 3363 participants whose age was ≥ 65 years old. TOD, including left ventricular hypertrophy (LVH), arterial stiffness (AS), lower extremity atherosclerotic (LEA), micro-albuminuria (MAU) and chronic kidney disease (CKD), was measured using standard methods. LAP was calculated as (WC– 65) × TG in men and (WC– 58) × TG in women. Both quartiles and continuation of LAP were analyzed. Results: Age-sex adjusted partial correlation analysis showed that LAP was significantly associated with CVD risk factors. With the first quartile (Q1) as a reference, in univariate logistic regression, the fourth quartile (Q4) of LAP was associated with all TOD. In multivariate model, Q4 of LAP was only associated with an increased risk of AS (odds ratio (OR) = 1.88, 95% confidence interval (CI): 1.37– 2.58, Pfor trend< 0.001), MAU (OR = 1.33, 95% CI: 1.01– 1.75, Pfor trend= 0.02) and CKD (OR = 2.39, 95% CI: 1.39– 4.12, Pfor trend< 0.001). But, Q4 of LAP was not associated with an increased risk of LVH (OR = 1.19, 95% CI: 0.85– 1.65, Pfor trend= 0.25) or LEA (OR = 0.87, 95% CI: 0.58– 1.29, Pfor trend= 0.96). Similar associations were found when analyzed continuously. Conclusion: The novel metabolic parameter LAP is significantly and independently associated with an increased risk of arterial stiffness, chronic kidney disease and micro-albuminuria in Chinese community-dwelling elderly individuals.

14 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
DSDi-Yang Sun
Di-Yang Sun
WWWen-Bin Wu
Wen-Bin Wu
JWJian-Jin Wu
Jian-Jin Wu
YSYu Shi
Yu Shi
JXJia-Jun Xu
Jia-Jun Xu
PWPei Wang
Pei Wang

1 May 2021 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
JXJing Xiong
Jing Xiong
YQYunyun Qian
Yunyun Qian
SYShikai Yu
Shikai Yu
HJHongWei Ji
HongWei Ji
JTJiadela Teliewubai
Jiadela Teliewubai
YXYawei Xu
Yawei Xu
Objective: To investigate the relationship between asymptomatic target organ damage (TOD) and different somatotypes in a population of elderly from Chinese community-dwelling. Methods: A total of 2098 Chinese senior residents from northern Shanghai older than 65 years were recruited in the research. The following somatotype parameters were recorded and analyzed: body mass index, waist circumference, hip circumference, and waist-hip ratio were recorded and calculated. Asymptomatic TOD, including urine albumin/creatinine ratio, estimated glomerular filtration rate (eGFR), intima-media thickness (IMT), left ventricular mass index (LVMI), left ventricular diastolic function, and carotid-femoral pulse wave velocity (PWV) was recorded using the MyLab30 Gold CV system and SphygmoCor. Results: Of all 2098 residents, 817 (38.9%) were overweight and 289 (13.8%) were obese. All somatotype measures were significantly correlated with TOD parameters (p< 0.05). After adjustment for age and male gender, in total population, LVMI (p< 0.001), cardiac diastolic function (E/Ea, p< 0.001), PWV (p< 0.001), eGFR (p=0.03), and urine albumin/creatinine ratio (p< 0.001) changed gradually and significantly correlated with increasing BMI values. Obesity and overweight were independently related to the incidence of LVH, LVDD, artery stiffness, carotid arterial plaque, and microalbuminuria. Conclusion: The incidence of asymptomatic TOD was significantly correlated with overweight and obesity, especially in women, whereas the underweight may favor in the prevention of TOD.

10 September 2022 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
CCChen Chi
Chen Chi
YLyi lu
yi lu
YZYiwu Zhou
Yiwu Zhou
JLJiaxin Li
Jiaxin Li
YXYawei Xu
Yawei Xu
yi zhangyi zhang
yi zhang
Calibration affects central blood pressure (BP) estimation accuracy. Factors influencing the accuracy of noninvasive central BP measurement, type of calibration method implemented (systolic/diastolic BP or mean/diastolic BP), and type of BP measurement device used (devices using the transfer function method, directly measurement from the carotid artery, and the transfer function-like method), were investigated. Fifty participants (aged 62.4 ± 8.9 years) without overt heart diseases were recruited. Invasive aortic and radial BP was measured. Simultaneously, noninvasive central BP was measured using three types of devices. The mean invasive aortic BP was 127 ± 19/95 ± 14 mmHg. Noninvasive central BP tended to be slightly lower than invasive BP, though without statistical significance. The type of calibration method did not significantly influence the noninvasive cSBP measurements (p ≥ 0.24). Results from cuff-based devices were significantly lower than invasive measurements (p = 0.04). Multiple regression analyses showed that gender was significantly correlated with the accuracy of noninvasive cSBP measurement. In conclusion, noninvasive cSBP measurements are comparable to invasive measurements but might underestimate true cSBP. The type of device may affect the accuracy of measurement. Either of the two calibration methods is acceptable.